69 results
6-K
EX-99.3
SOPH
SOPHiA Genetics SA
5 Mar 24
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
7:00am
to continue to access U.S. capital markets.
Use of estimates
The preparation of consolidated financial statements in conformity with IFRS Accounting … to perform analyses under three different models: dry lab access; bundle access; and integrated solutions.
For dry lab contracts, customers use the testing
6-K
EX-99.5
SOPH
SOPHiA Genetics SA
5 Mar 24
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
7:00am
the SOPHiA DDM Platform to perform analyses under three different models: dry lab access; bundle access; and integrated solutions.
For dry lab … network and access their data through the SOPHiA DDM Platform. The Company has identified one performance obligation, which is delivery
6-K
EX-99.2
SOPH
SOPHiA Genetics SA
5 Mar 24
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
7:00am
public gained access to powerful AI models and learned what they can do. As the Co-founder and leader of an AI-driven precision medicine company … entered into a partnership with MSK to help them to decentralize their Liquid Biopsy test MSK-ACCESS® and their Solid Tumor test MSK-IMPACT®, and to make
6-K
EX-99.1
SOPH
SOPHiA Genetics SA
5 Mar 24
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
7:00am
51% since Q4 2022
Launched a new, expanded suite of Liquid Biopsy applications in December 2023, including MSK-ACCESS powered with SOPHiA DDMTM … Deficiency (HRD) testing and Latin American healthcare network Diagnosticos da America (DASA) who adopted MSK-ACCESS powered with SOPHiA DDMTM
6-K
EX-99.2
2lwaneynjnq gsrp
10 Jan 24
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
4:59pm
6-K
EX-99.1
dwaub1r
10 Jan 24
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
4:59pm
6-K
EX-99.2
hgawnx1jv90naq2 tnp
7 Nov 23
Index to Consolidated Financial Statements
7:02am
6-K
EX-99.3
v6b9k26wfgicb
7 Nov 23
Index to Consolidated Financial Statements
7:02am
6-K
EX-99.1
4k9jnugrbv5mvoddw2w
18 Oct 23
The three companies will collaborate to improve global access to advanced cancer testing and data, broadening access to cutting edge science
12:12pm
6-K
EX-99.1
3dmtgv21vuwdvs1m
14 Aug 23
Current report (foreign)
8:41am
6-K
EX-1.1
kon4beny5n8rzlq7hef0
8 Aug 23
Current report (foreign)
5:17pm
6-K
EX-99.2
4b44i3l
8 Aug 23
Index to Consolidated Financial Statements
7:14am
6-K
EX-99.3
8d5kzh8xbv3qcxn
8 Aug 23
Index to Consolidated Financial Statements
7:14am
6-K
EX-99.1
lzkbxgarttg
6 Jun 23
Current report (foreign)
6:00am
6-K
EX-99.1
veqg1hyb0 sta
17 May 23
Invitation to the Annual General Meeting
6:01am
6-K
EX-99.2
7hqgcmcz ymjflqiq1en
17 May 23
Invitation to the Annual General Meeting
6:01am
6-K
EX-99.1
4iwzy83
12 May 23
Current report (foreign)
6:05am
6-K
EX-99.3
1xi3sz5qc vnty0jw
9 May 23
Index to Consolidated Financial Statements
7:08am
6-K
EX-99.2
quofo7
9 May 23
Index to Consolidated Financial Statements
7:08am